You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diffuse large B-cell lymphoma

Showing 9926 - 9950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Prostate Cancer Trial in Canada, United States (18F-DCFPyL Injection, PET/CT imaging)

Completed
Has Results
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • PET/CT imaging
  • San Francisco, California
  • +9 more
Aug 6, 2021

Group B Streptococcus Carrier in Childbirth, Gastrointestinal Symptoms Trial in Milwaukee (Florajen3)

Active, not recruiting
  • Group B Streptococcus Carrier in Childbirth
  • Gastrointestinal Symptoms
  • Florajen3
  • Milwaukee, Wisconsin
    Aurora Sinai Medical Center
Aug 11, 2022

Spending and Outcomes for Complex Medicare Advantage Patients

Completed
  • Kidney Failure, Chronic
    • (no location specified)
    Feb 6, 2022

    Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab, Sinoporphyrin Sodium, Photodynamic therapy)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital & Institute
    Nov 23, 2022

    Cardiovascular Complications of Sickle Cell Disease

    Completed
    Has Results
    • Sickle Cell Disease
    • MRI, Transthoracic Echocardiography, tonometry, EKG
    • Chicago, Illinois
      University of Chicago Medical Center
    Feb 8, 2022

    Sjogren's Syndrome, Autoimmune Diseases Trial in Hangzhou (Assigned Interventions CD19/BCMA CAR T-cells)

    Recruiting
    • Sjogren's Syndrome
    • Autoimmune Diseases
    • Assigned Interventions CD19/BCMA CAR T-cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 11, 2021

    Pulmonary Osteosarcoma Trial (RNA-LP vaccine)

    Not yet recruiting
    • Pulmonary Osteosarcoma
    • RNA-LP vaccine
    • (no location specified)
    Jan 25, 2023

    Rheumatoid Arthritis Trial in France (Xrays, Ultrasound (B mode ), Ultrasound (D mode))

    Active, not recruiting
    • Rheumatoid Arthritis
    • Xrays
    • +2 more
    • Angers, France
    • +9 more
    May 7, 2022

    Squamous Cell Carcinoma, RP1 Trial (RP1)

    Not yet recruiting
    • Squamous Cell Carcinoma
    • RP1
    • (no location specified)
    May 4, 2023

    AML Trial in Hangzhou (NKG2D CAR-NK)

    Recruiting
    • AML
    • NKG2D CAR-NK
    • Hangzhou, Zhejiang, China
    • +1 more
    Feb 17, 2023

    IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;Peripheral Trial in Boston (Acalabrutinib, Rituximab)

    Recruiting
    • IgM MGUS
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

    Recruiting
    • Acute Myeloid Leukemia
    • Decitabine and Cedazuridine
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 10, 2022

    Cognitive Decline, Blood Pressure, Hypertension Trial in Dallas (Clinical Support Decision Tool)

    Recruiting
    • Cognitive Decline
    • +2 more
    • Clinical Support Decision Tool
    • Dallas, Texas
      UT Southwestern Medical Center
    Aug 29, 2022

    MDS Trial in Beijing (Roxadustat, Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 17, 2023

    Head and Neck Tumors Trial in Tainan, Taipei (SCB01A)

    Terminated
    • Head and Neck Neoplasms
    • Tainan, Taiwan
    • +3 more
    Jun 22, 2022

    Oral Cancer, VEGFR2 Inhibitor, Programmed Cell Death 1 Inhibitor Trial in Shanghai (drug, procedure, radiation)

    Active, not recruiting
    • Oral Cancer
    • +3 more
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital
    Jul 23, 2021

    Blood Vessel Study

    Completed
    • Cardiovascular Disease
      • Research Triangle Park, North Carolina
        NIEHS Clinical Research Unit (CRU)
      Jan 25, 2023

      Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)

      Enrolling by invitation
      • Immune Tolerance
      • Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
      • Palo Alto, California
        Stanford University
      May 6, 2022

      Chronic Hepatitis b Trial in Chisinau, Kyiv (ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet)

      Terminated
      • Chronic Hepatitis b
      • ATI-2173 25mg
      • +2 more
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      May 25, 2022

      Intraoperative Hemodynamics, Liposuction Trial in Tanta (Epinephrine concentration of 1:1000000, Epinephrine concentration of

      Not yet recruiting
      • Intraoperative Hemodynamics
      • Liposuction
      • Epinephrine concentration of 1:1000000
      • Epinephrine concentration of 1:500000
      • Tanta, Egypt
        Neveen Kohaf
      Apr 20, 2023

      CAR, Acute Myeloid Leukemia Trial in Hefei (TAA05 cell injection)

      Recruiting
      • CAR
      • Acute Myeloid Leukemia
      • TAA05 cell injection
      • Hefei, Anhui, China
        Anhui Provincial Hospital
      Nov 3, 2021

      Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

      Recruiting
      • Relapsing Multiple Sclerosis
      • +2 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • Best Available Therapy (BAT)
      • Palo Alto, California
      • +20 more
      Jan 25, 2023

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

      Suspended
      • Anatomic Stage I Breast Cancer AJCC v8
      • +23 more
      • Short-Term Fasting
      • Chemotherapy
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Jan 23, 2023

      Urothelial Carcinoma Trial in Worldwide (Zilovertamab vedotin)

      Recruiting
      • Urothelial Carcinoma
      • Zilovertamab vedotin
      • Cleveland, Ohio
      • +11 more
      Jan 25, 2023